These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8273140)

  • 1. Use of white cell-reduced red cells for transfusion through peripheral arterial lines.
    Derleth DP
    Transfusion; 1994 Jan; 34(1):86. PubMed ID: 8273140
    [No Abstract]   [Full Text] [Related]  

  • 2. Biocompatibility of leukocyte removal filters during bedside leukocyte filtration of red cell concentrates.
    Gu YJ; Obster R; de Haan J; Huet RC; van Oeveren W
    Transfus Sci; 1992; 13(4):467-72. PubMed ID: 10147741
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of alloimmunization is first priority in platelet transfusion].
    Yu JR
    Zhonghua Nei Ke Za Zhi; 1993 Feb; 32(2):78-9. PubMed ID: 8404328
    [No Abstract]   [Full Text] [Related]  

  • 4. Granulocyte transfusion therapy.
    Price TH
    J Clin Apher; 2006 Apr; 21(1):65-71. PubMed ID: 16619227
    [No Abstract]   [Full Text] [Related]  

  • 5. [Special features of blood transfusions to hematologic patients].
    Oksanen K
    Duodecim; 1998; 114(12):1233-9. PubMed ID: 11524769
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood component therapy.
    Fasano R; Luban NL
    Pediatr Clin North Am; 2008 Apr; 55(2):421-45, ix. PubMed ID: 18381094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of white cell-reduced blood components for transfusions during early infancy.
    Strauss RG
    Transfusion; 1993 Apr; 33(4):352-7. PubMed ID: 8480358
    [No Abstract]   [Full Text] [Related]  

  • 8. Leucocyte depletion of blood components.
    Bird A
    S Afr Med J; 2001 Oct; 91(10):822-3. PubMed ID: 11732450
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of leucocyte depletion on the generation and removal of microvesicles and prion related protein in blood components.
    Krailadsiri P; Perry R; Drummond O; Smith K; Hockley D; Seghatchian J; Spring F; Macgregor I; Williamson L; Prowse C; Lubenko A; Anstee D; Barrowcliffe T; Turner M
    Transfus Apher Sci; 2001 Dec; 25(3):177-8. PubMed ID: 11846133
    [No Abstract]   [Full Text] [Related]  

  • 10. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions.
    Pruss A; Kalus U; Radtke H; Koscielny J; Baumann-Baretti B; Balzer D; Dörner T; Salama A; Kiesewetter H
    Transfus Apher Sci; 2004 Feb; 30(1):41-6. PubMed ID: 14746820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based recommendations for the use of WBC-reduced cellular blood components.
    Ratko TA; Cummings JP; Oberman HA; Crookston KP; DeChristopher PJ; Eastlund DT; Godwin JE; Sacher RA; Yawn DH; Matuszewski KA;
    Transfusion; 2001 Oct; 41(10):1310-9. PubMed ID: 11606834
    [No Abstract]   [Full Text] [Related]  

  • 12. Universal leukoreduction of cellular blood components in 2001?
    Garcia A; Veillon DM; McCaskill D
    Am J Clin Pathol; 2001 Nov; 116(5):778-80. PubMed ID: 11710697
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components.
    Dzieczkowski JS; Barrett BB; Nester D; Campbell M; Cook J; Sugrue M; Andersen JW; Anderson KC
    Transfusion; 1995 Jan; 35(1):20-5. PubMed ID: 7998063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical applications of stem cell transfusion from cord blood.
    Gluckman E; Thierry D; Lesage S; Traineau R; Gerotta J; Rabian C; Brossard Y; Van Nifterik J; Benbunan M
    Transfus Sci; 1992; 13(4):415-21. PubMed ID: 10147739
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pediatric preparations of blood products].
    Boulat C
    Transfus Clin Biol; 2017 Sep; 24(3):237-239. PubMed ID: 28728892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical issues in neonatal transfusion practice.
    Strauss RG
    Am J Clin Pathol; 1997 Apr; 107(4 Suppl 1):S57-63. PubMed ID: 9124231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for elective red blood cell transfusion.
    Ross JM
    Ann Intern Med; 1992 Sep; 117(5):441; author reply 442. PubMed ID: 1503338
    [No Abstract]   [Full Text] [Related]  

  • 18. Transfusion guidelines for neonates and older children.
    Gibson BE; Todd A; Roberts I; Pamphilon D; Rodeck C; Bolton-Maggs P; Burbin G; Duguid J; Boulton F; Cohen H; Smith N; McClelland DB; Rowley M; Turner G;
    Br J Haematol; 2004 Feb; 124(4):433-53. PubMed ID: 14984493
    [No Abstract]   [Full Text] [Related]  

  • 19. [Methodological approaches toward higher safety of hemotransfusion therapy].
    Moskalenko VF; Orlyk VV; Gorban' IeM; Novak VL
    Lik Sprava; 2000 Sep; (6):3-8. PubMed ID: 11452914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion Considerations in Pediatric Hematology and Oncology Patients.
    Bercovitz RS; Josephson CD
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):695-709. PubMed ID: 27113005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.